Dogu, M. H. Et Al. 2023. Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results. Mediterranean Journal of Hematology and Infectious Diseases , vol.15, no.1 .

Dogu, M. H., Emre Tekgunduz, A. I., Deveci, B., Korkmaz, G., Comert, M., SEVİNDİK, Ö. G., ... Yokus, O.(2023). Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results. Mediterranean Journal of Hematology and Infectious Diseases , vol.15, no.1.

Dogu, Mehmet Et Al. "Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results," Mediterranean Journal of Hematology and Infectious Diseases , vol.15, no.1, 2023

Dogu, Mehmet H. Et Al. "Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results." Mediterranean Journal of Hematology and Infectious Diseases , vol.15, no.1, 2023

Dogu, M. H. Et Al. (2023) . "Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results." Mediterranean Journal of Hematology and Infectious Diseases , vol.15, no.1.

@article{article, author={Mehmet Hilmi Dogu Et Al. }, title={Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results}, journal={Mediterranean Journal of Hematology and Infectious Diseases}, year=2023}